At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the world’s biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference.
 

Every member of Gilead’s team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we’re looking for the next wave of passionate and ambitious people ready to make a direct impact.
 

We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Gilead and help create possible, together.

Job Description
 

At Gilead our pursuit of a healthier world for all people has yielded a cure for hepatitis C, revolutionary improvements in HIV

treatment and prevention as well as advancements in therapies for viral and inflammatory diseases and certain cancers.

We set and achieve bold ambitions in our fight against the world’s most devastating diseases, united in our commitment to

confronting the largest public health challenges of our day and improving the lives of patients for generations to come. As a

Senior Director – Inflammation, at Gilead you will lead early commercialization strategy for pipeline assets across inflammation and immunology, representing the commercial perspective from pre‑clinical development through early and mid‑stage clinical programs.

Reporting to the Vice President, Global Commercial Liver, Inflammation, COVID‑19 and Established Products, this role is accountable for guiding pre‑proof‑of‑concept (pre‑POC) and early commercialization activities to inform development decisions, product profiles, and investment priorities. The role operates in a highly cross‑functional environment and is responsible for integrating market, payer, provider, patient, and competitive insights into development strategy to maximize long‑term patient impact and commercial value.

Key responsibilities include:

• Lead Early Commercialization Teams and partner with Global Asset Teams from pre‑clinical development through initiation of Phase III, ensuring clear transition to inline teams as programs enter late‑stage development

• Provide commercial input into development strategy, target product profiles, and portfolio prioritization decisions

• Synthesize commercial insights to support evaluation of business development opportunities, including acquisitions and partnerships

• Guide teams in developing deep understanding of disease landscapes, unmet need, competitive dynamics, and stakeholder perspectives

• Partner with Global Value & Access, Commercialization, Medical Affairs, Development, and selected country teams to integrate global and local insights into cohesive strategies

• Serve as the commercial lead for selected partnered or collaborative pipeline programs

• Support early commercialization planning activities as appropriate, including foundational branding, positioning, and launch readiness considerations

Success in this role is measured by the development of differentiated pipeline assets that are positioned to maximize patient reach, long‑term value, and sustainable impact.

Basic Qualifications:

Bachelor’s degree and fourteen (14) years of relevant experience

or

Master’s degree and twelve (12) years of relevant experience

or

PhD and twelve (12) years of relevant experience

Preferred Qualifications:

·Experience in inflammation, immunology, liver disease, or related therapeutic areas

·Demonstrated experience influencing product development decisions through early commercialization strategy

·Experience evaluating pipeline assets, partnerships, or business development opportunities

·Knowledge of global value, access, and pricing strategy, including development of value narratives and evidence planning

·Familiarity with U.S. payer dynamics and global market access considerations

·Strong ability to build collaborative